Results 121 to 130 of about 529,428 (208)
ABSTRACT Background Neuromuscular blocking agents are recommended by the European Society of Anaesthesiology and Intensive Care (ESAIC) and European Society of Paediatric Anaesthesia (ESPA) for facilitating tracheal intubation in children. Despite these recommendations, real‐world data on how neuromuscular blocking agents are used, monitored, and ...
Giulia Bonatti +8 more
wiley +1 more source
SURVIVAL OF A MALIGNANT HYPERTHERMIA PATIENT
Malignant hyperthermia is an inherited autosomal life threatening skeletal muscle disorder usually triggered by certain general anesthetic drugs like volatile anesthetics and depolarizing muscle relaxants (succinylcholine).
Liaquat Ali +3 more
doaj +2 more sources
A 9‐year‐old spayed female dog presented with a solitary, well‐demarcated, intensely vascular abdominal mass closely associated with the aortic trifurcation on advanced imaging. Exploratory laparotomy confirmed that the lesion was unresectable because of its anatomical relationships and the risk of catastrophic haemorrhage.
Seyed Amirreza Boskabadi +4 more
wiley +1 more source
Summary There are limited case reports of hypersensitivity reactions to neuromuscular blocking agents (NMBAs) in veterinary species, and none describe cutaneous‐only signs. This case report describes a Grade 1 cutaneous‐only hypersensitivity reaction to atracurium in a 7‐year‐old dog undergoing general anaesthesia for cataract surgery with bilateral ...
Kar Yee Phoon, Rob Ward
wiley +1 more source
Abstract A 5‐year‐old, spayed, female Shiba Inu was presented with a 6‐week history of reduced appetite, lethargy and generalised stiffness, which showed only limited improvement despite anti‐inflammatory treatment. The most significant clinical abnormalities were pyrexia, stiffness, pain on joint manipulation and cutaneous lesions. Laboratory findings
Jeanne Bergeat +6 more
wiley +1 more source
Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept
This article reviews advancements in the genetics of malignant hyperthermia, new technologies and approaches for its diagnosis, and the existing limitations of genetic testing for malignant hyperthermia. It also reviews the various RYR1-related disorders
Kraeva, N +5 more
core +1 more source
Challenges in the management of malignant hyperthermia in Colombia: Case report
Malignant hyperthermia is a potentially life-threatening pharmacogenetic disorder characterized by a hypermetabolic response triggered by exposure to halogenated anesthetics, succinylcholine, and other agents.
Camila Andrea Lara Rosero +2 more
doaj +1 more source
Fulminant brachycephalic obstructive airway syndrome in a 3‐month‐old French bulldog
Abstract A 3‐month‐old, entire, female French bulldog (6.4 kg) presented in severe respiratory distress with hyperthermia and cyanosis. Laryngeal examination revealed severe obstruction by oedematous tissue, later confirmed as bilaterally everted laryngeal saccules; the airway was stabilised by tracheal intubation.
Yasumasa Iimori +4 more
wiley +1 more source
Targeting CKIP‐1 for Disease Therapy: Cellular Functions, Molecular Networks, and Clinical Potential
CKIP‐1, as a scaffold protein with special structural domains, treats related diseases through multiple emerging targeted technologies.
Xin Huang +4 more
wiley +1 more source

